Key Points
- TGA approves a new oral medicine for COVID-19 treatment
- National cabinet to discuss reducing isolation period on 31 August
- Pfizer seeks approval for a booster dose that targets BA.4 and BA.5 subvariants
On Tuesday, Australia reported at least 95 COVID-19 deaths, including 32 in New South Wales, 26 in Queensland and 25 in Victoria.
Prime Minister Anthony Albanese said there would be a further inquiry after former prime minister Scott Morrison's secret appointment to the Department of Industry, Science, Energy and Resources portfolio was found valid.
"We will make a future announcement about an inquiry. This isn't something that can be just dismissed," Albanese said. Mr Morrison had appointed himself to five portfolios during the pandemic.
Assistant Minister for Mental Health Emma McBride has launched a new helpline Head to Health service.
Residents can call 1800 595 212 from 8:30 am to 5 pm to receive free advice, assessment and referral to mental health services.
Pfizer has sought the US Food and Drug Administration approval for a booster dose that targets Omicron's BA.4 and BA.5 subvariants.
The Therapeutic Goods Administration has approved sabizabulin, a new oral medicine to treat hospitalised patients with moderate-to-severe COVID-19 infection.
NSW Premier Dominic Perrottet will again raise the issue of reducing the quarantine period from seven to five days for people with COVID-19 at the next meeting of national cabinet on 31 August.
Find a COVID-19 testing clinic
Register your RAT results here, if you're positive
Read all COVID-19 information in your language on the
